This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Merck Canada Inc., Merck Sharp + Dohme Corp.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015-2017
I specialize in innovations, inventions, inventors, patent attorneys, assignees and patents.
Title: Inventor Spotlight - Marie-Eve Lebrun
Introduction:
Marie-Eve Lebrun, a prolific inventor based in Dollard-des-Ormeaux, CA, has made significant contributions to the field of pharmaceuticals with his inventive spirit and dedication. With a total of 2 patents to his name, Marie-Eve Lebrun is a trailblazer in the realm of biotechnology and drug development.
Latest Patents:
Marie-Eve Lebrun's latest patents include groundbreaking inventions that have the potential to revolutionize the treatment of various diseases. One of his patents is for thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors, which has paved the way for novel pharmaceutical compositions aimed at treating diseases mediated by Spleen Tyrosine Kinase (Syk). His other patent pertains to sulfonamides as HIV protease inhibitors, offering new avenues for the prophylaxis and treatment of HIV infections and AIDS.
Career Highlights:
Having worked at reputable companies such as Merck Canada Inc. and Merck Sharp & Dohme Corporation, Marie-Eve Lebrun has honed his skills and expertise in the pharmaceutical industry. His innovative mindset and dedication to improving healthcare have led to the successful development and patenting of cutting-edge pharmaceutical compounds.
Collaborations:
Throughout his career, Marie-Eve Lebrun has collaborated with esteemed professionals in the field of biotechnology and drug development. Notable coworkers include Oscar Miguel Moradei and Sheldon N. Crane, who have worked alongside Marie-Eve Lebrun in various research projects and patent applications.
Conclusion:
Marie-Eve Lebrun's exceptional contributions to the field of pharmaceutical research have positioned him as a pioneering inventor in the industry. His groundbreaking patents and collaborations underscore his commitment to advancing healthcare and developing innovative solutions for treating complex diseases. Marie-Eve Lebrun's journey as an inventor serves as a testament to the transformative power of innovation and dedication in the realm of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile